Goldman Sachs Maintains Buy on CareDx, Raises Price Target to $35

Benzinga · 10/16 13:30
Goldman Sachs analyst Matthew Sykes maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $26 to $35.